BSE filing, NSE: TVSSCS. Summary written from the filing by ALFA Finder's alert engine.
TVS Supply Chain Solutions Ltd: key numbers
- Share price
- ₹111.43
- Market cap
- ₹4,917 Cr
- Revenue (annual)
- ₹11,003 Cr
- Net profit (annual)
- ₹114.3 Cr
- P/E (TTM)
- 75.9×Sector 30.1×
- Promoter holding
- 43.03%+0.00% QoQ
- FII holding
- 2.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TVS Supply Chain Solutions Ltd
All →TVS Supply Chain Solutions Acquisition Worth ₹10.19 Cr
TVS SCS acquires 51% stake in TVS SCS ALA India for ₹10.19 Crore. The move targets aerospace and defense logistics business expansion.
- Value
- ₹10.19 Cr
TVS Supply Chain Solutions Merger & Restructuring Worth ₹19.99 Cr
TVS SCS and partner ALA Mena each subscribed to shares in their JV, TVS SCS ALA India, for a total of ₹19.99 Crore.
- Value
- ₹19.99 Cr
TVS Supply Chain Solutions Acquisition
TVS Supply Chain Solutions has received NCLT Bengaluru Bench sanction for its Scheme of Amalgamation involving multiple transferor companies, completing the necessary regulatory approvals.
TVS Supply Chain Solutions Partnership
TVS Supply Chain Solutions signed a strategic MoU with Japan's Sankyu Inc. for supply chain and engineering services. Sankyu also intends to acquire a 0.5% equity stake.
TVS Supply Chain Solutions Earnings Call Transcript: Key Takeaways
TVS Supply Chain Solutions reported record Q1 FY27 revenue of Rs. 3,335.2 Cr, up 29% YoY. Strategy focuses on tech-led, asset-light solutions across ISCS and GFS segments with margin expansion.
- Call
- Guides 15% growth
TVS Supply Chain Solutions Investor Presentation: Key Takeaways
TVS Supply Chain Solutions reported strong Q1 FY27 results with 28.7% YoY revenue growth to INR 3,335 Cr, driven by significant new business wins and operational excellence.
- Call
- Guides 15% growth
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.